Displaying 10 out of 13 results

  1. The Ericsson logo is seen at the Ericsson's headquarters in Stockholm

    Swedish gearmaker Ericsson expects 2.6 billion 5G subscriptions by end of 2025

    Sweden's Ericsson expects the number of 5G subscriptions to reach 2.6 billion by the end of 2025, up from 13 million in 2019, with network ...
  2. The ESPN logo is seen on an electronic display in Times Square in New York City

    ESPN criticised over China-NBA coverage for using 'nine-dash line' map

    The sports network ESPN faced fresh criticism of its coverage of a row between the National Basketball Association (NBA) and China after using a ...
  3. The Wider Image: Life in California's largest immigration detention center

    US prisons lose Wall Street sell-side coverage

    Sell-side analysts have stopped covering U.S. private prison operators as Wall Street has distanced itself from publicly traded GEO Group Inc and ...
  4. FILE PHOTO: Wimbledon

    Network defends Barty snub after 'sexist' broadcast claims

    Australian broadcaster Seven Network has defended its decision to televise Nick Kyrgios's first round match rather than world number one Ash ...
  5. A sign on an insurance store advertises Obamacare in San Ysidro

    Supreme Court to hear insurers' bid for US$12 billion in Obamacare money

    The U.S. Supreme Court on Monday agreed to decide whether the federal government must pay insurers US$12 billion under an Obamacare program aimed ...
  6. The Ericsson logo is seen at the Ericsson's headquarters in Stockholm

    Swedish gearmaker Ericsson increases 5G forecasts

    Sweden's Ericsson has raised its forecast for 5G subscriptions by 27 percent to 1.9 billion by 2024, with network coverage offering access to 45 ...
  7. Amgen's migraine treatment, Aimovig, which has been prescribed to more than 200,000 patients s

    The obscure advisory committees at the heart of the US drug pricing debate

    Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.